We anticipate that the public availability of CICERO will also lead to improved fusion analysis for adult cancer RNA-seq data, as demonstrated through our re-analysis of TCGA GBM in this study and our recent discovery of MAP3K8 C-terminal truncation fusion in 2% of TCGA melanoma samples [5]. This evidence concerns the gene MAP3K8 and cancer.